Tuesday 28 August 2018

FDA Draft Guidance: Hematologic Malignancy and Oncologic Disease: Considerations for Use of Placebos and Blinding in Randomized Controlled Clinical Trials for Drug Product Development Guidance for Industry

submitted by /u/BSP_
[link] [comments]

from Health https://ift.tt/2Lzaz8W
via IFTTT

No comments:

Post a Comment